ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

WG. Wood Group (john) Plc

147.30
-2.10 (-1.41%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Wood Group (john) Plc LSE:WG. London Ordinary Share GB00B5N0P849 ORD 4 2/7P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.10 -1.41% 147.30 148.20 148.50 149.70 146.30 148.40 1,861,372 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Engineering Services 5.9B 464M 0.6707 2.21 1.03B

Wood Group (John)PLC Wood Wins Contract for Biotech Facility

23/05/2018 7:00am

UK Regulatory


 
TIDMWG. 
 
23 May 2018 
 
           Wood wins contracts for Teva Biotech facility in Germany 
 
Wood has been awarded a $US multi-million contract by TEVA Biotech GmbH to 
provide engineering, procurement, construction management, commissioning and 
qualification (EPCmQ) for a new biotechnological facility to be built in Ulm, 
Germany. 
 
The plant will produce pharmaceutical ingredients from cell cultures in a new 
eight-storey building to be constructed within TEVA's existing biotechnology 
production site. 
 
Wood EAAA Capital Projects Group will execute detailed design and procurements 
services for a lump sum fee, as well as construction management and 
commissioning/qualification services under a reimbursable contract. Expected 
completion will be 2020, while tech transfer is planned to begin in 2021. 
 
Prior to this award, Wood completed basic design and an investment cost 
estimate for the same facility under a previous contract, which was awarded on 
a competitive basis. 
 
Robin Watson, chief executive of Wood, said:  "This contract reflects TEVA's 
trust in our ability to execute projects of this size in Germany and validates 
our global expertise in the development of active pharmaceutical ingredient 
facilities. We will draw upon our local knowledge, global resources, and four 
decades of experience working with the world's top drug manufacturers to 
deliver a state-of-the-art facility to TEVA." 
 
This important contract increases Wood's share in the pharmaceutical market and 
enhances the company's scale and diversity in Europe. 
 
                                    -ends- 
 
Note to Editors: 
 
Wood is a global leader in the delivery of project, engineering and technical 
services to energy and industrial markets. We operate in more than 60 
countries, employing around 55,000 people, with revenues of around $10 
billion.  We provide performance-driven solutions throughout the asset life 
cycle, from concept to decommissioning across a broad range of industrial 
markets, including the upstream, midstream and downstream oil & gas, power & 
process, environment and infrastructure, clean energy, mining, nuclear, and 
general industrial sectors. We strive to be the best technical services company 
to work with, work for and invest in. www.woodplc.com 
 
For further information contact:  press.office@woodplc.com 
 
 
 
END 
 

(END) Dow Jones Newswires

May 23, 2018 02:00 ET (06:00 GMT)

1 Year Wood Group (john) Chart

1 Year Wood Group (john) Chart

1 Month Wood Group (john) Chart

1 Month Wood Group (john) Chart

Your Recent History

Delayed Upgrade Clock